Tamara Music joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in 2007 and is a Manager leading the Influenza Vaccines Supply (IVS) International Task Force as well as the transparency and ethics initiatives which include the IFPMA Code of Practice and the Code Compliance Network (CCN). Previously, Tamara has also worked on global health policy topics related to healthcare systems and market access. Tamara received her B.A. in Political Science from University of California, Berkeley, her Masters in International Affairs from the Graduate Institute in Geneva, and Certificate of Advanced Studies (CAS) in Pharmaceutical Economics and Policy from University of Lausanne, School of Business (HEC).

Dr. Luheshi has been with Johnson & Johnson for 14 years, of which 5 years as Head of Compliance for LifeScan EMEA and 4 years leading the health care compliance team for Janssen Pharmaceuticals in Asia. Currently based between the UK and China overseeing program enhancement initiatives for Johnson & Johnson

Experience includes: implementation of international compliance program (developed, developing and emerging markets); anti-bribery/anti-corruption / FCPA investigations; risk assessments across multi-jurisdictional organizations; responses to external regulatory enforcement actions and management of third party relationships with respect to risk mitigation.

Originally an organic chemist, post-MBA has held posts in operations management and finance across the chemical, agrichemical and healthcare industries.

Roeland joined Johnson & Johnson in 1987 as a Medical Representative for Janssen Pharmaceutica. He held various positions of increasing responsibility in both sales and marketing and joined the WWOHCC&P in May 2005 for the EMEA region with extension to Asia, Latin-America and Canada in 2008. In 2010 Roeland became responsible for EMEA & Canada cross sector. Regional Vice President - HCCO MD&D EMEA & Canada is his current position since October 2012. Currently he also fulfills the Chairman role of the EUCOMED compliance network and is a member of the board and a founding member of ETHICS.

Heather Simmonds is the Director of the Prescription Medicines Code of Practice Authority (PMCPA). Heather chairs the Code of Practice Panel, which considers complaints submitted under the Code in the first instance, and is responsible for the overall running of the organisation. Heather also works with IFPMA and EFPIA in relation to their codes of practice.

Heather has a degree in pharmacology and joined the ABPI in 1984. Heather has been working full time on the Code of Practice since 1989 and has been Director of the Authority since 1997.

Dominique Laymand is Vice-President Compliance & Ethics EMEA (Europe, Middle East, Turkey, Russia and Africa). In this role, Dominique is responsible for maintaining, monitoring and controlling the Compliance & Ethics program based on an integrated approach of risks in terms of prevention, detection and control. She works closely with the EMEA Business leadership teams to establish policy oversight and governance via an efficient and effective Compliance & Ethics Program. She has a particular focus on Business Practices and is a member of operational committees as well as the Bristol-Myers Squibb Corporate Compliance Council and Anti-Bribery Committee.

Dominique has a broad experience at Bristol-Myers Squibb, having started with the company in 1983 as Legal Counsel.

Dominique is an active member of various Pharmaceutical Industry Associations and committees, proactively addressing Trust, Reputation and Compliance matters. She is the President of ETHICS Association; President of the Compliance Committee at the European Federation of Pharmaceutical Industries and Associations (EFPIA) and at the Compliance Committee at the LEEM (French Pharmaceutical Industry Association).

Jose Zamarriego has been the Director of the Code of Practice Surveillance Unit of the National Association of the Pharmaceutical Industry in Spain (Farmaindustria) since the establishment of this Compliance Control Body in 2004. Together with his team he oversees implementation and compliance with the self-regulation system of the pharmaceutical industry, adapting and anticipating to the growing demands of a society in constant evolution. At a European level, Jose is Chair of the EFPIA (European Federation of Pharmaceutical Industries and Associations) Code Compliance Committee and Vice-Chair of the Compliance Committee. He is also Chairman of the IFPMA (International Federation of Pharmaceutical Manufacturers & Associations) Code Complaint Procedure Adjudication Group. He has actively participated in several modifications of national, European and worldwide codes of practice for the pharmaceutical industry. Jose completed his PhD. on Economics & Business Studies in the Universidad Complutense de Madrid, expanding his education with an MBA on Business Administration by the University of Wales and a General Management Program by the IESE Business School. Before joining the innovative pharma association, he was General Secretary and General Director of the Spanish Generic Pharmaceutical Manufacturers Association (AESEG). Jose also has a background as an educator in the Universidad Europea de Madrid (UEM), where he was Dean of the Faculty of Economics and Business Administration and Executive Director of the UEM General Foundation.

Heather Simmonds is the Director of the Prescription Medicines Code of Practice Authority (PMCPA). Heather chairs the Code of Practice Panel, which considers complaints submitted under the Code in the first instance, and is responsible for the overall running of the organisation. Heather also works with IFPMA and EFPIA in relation to their codes of practice.

Heather has a degree in pharmacology and joined the ABPI in 1984. Heather has been working full time on the Code of Practice since 1989 and has been Director of the Authority since 1997.